StonvexLoading…
StonvexStonvexStonvexCore line items from RELY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $495.90M | $452.80M | $1.64B | $1.19B | $773.48M |
Operating Income | Not available | $53.74M | $77.47M | $38.65M | $26.88M |
Net Income | Not available | $49.05M | $67.93M | $26.72M | $6.54M |
EPS (Diluted) | $0.13 | $0.23 | $0.31 | $0.12 | $0.08 |
Total Assets | Not available | $1.39B | $1.46B | $1.21B | $1.17B |
Total Liabilities | Not available | $478.34M | $589.92M | $416.52M | $401.25M |
Cash & Equivalents | Not available | $649.06M | $542.43M | $476.90M | $515.90M |
Free Cash Flow OCF − CapEx | Not available | $75.91M | $295.65M | $152.39M | $147.54M |
Shares Outstanding | Not available | 210.33M | 210.63M | 209.33M | 206.09M |